APA (7th ed.) Citation

Peng, X., Shi, X., Chen, H., Cao, L., Zuo, H., Guo, J., . . . Luo, X. (2026). Decitabine promotes degradation of DNMT1 and EZH2 via the ubiquitination pathway and inhibits colorectal cancer progression. Cellular Oncology (2211-3428), 49(1), 1. https://doi.org/10.1007/s13402-025-01136-8

Chicago Style (17th ed.) Citation

Peng, Xiao-Mei, Xin-Peng Shi, Han Chen, Lu-Yang Cao, Hao-Jian Zuo, Jie-Qiong Guo, Nan Jiang, and Xiao-Yong Luo. "Decitabine Promotes Degradation of DNMT1 and EZH2 via the Ubiquitination Pathway and Inhibits Colorectal Cancer Progression." Cellular Oncology (2211-3428) 49, no. 1 (2026): 1. https://doi.org/10.1007/s13402-025-01136-8.

MLA (9th ed.) Citation

Peng, Xiao-Mei, et al. "Decitabine Promotes Degradation of DNMT1 and EZH2 via the Ubiquitination Pathway and Inhibits Colorectal Cancer Progression." Cellular Oncology (2211-3428), vol. 49, no. 1, 2026, p. 1, https://doi.org/10.1007/s13402-025-01136-8.